Drospirenone
2 NDCs across 1 manufacturer|0 Generic,2 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on May 23, 2019. In 2024, Medicare Part D spent $2 million on Drospirenone across 6,063 claims for 1,718 beneficiaries.
Drospirenone is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $6.61 to $6.61 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$6.61 – $6.61
per EA
7d Activity
avg -0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing DROSPIRENONE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SLYND 4 MG TABLET | $6.6124 per EA | -0.01% |
SLYND 4 MG TABLET | $6.6124 per EA | -0.01% |
Frequently Asked Questions
How much does Medicare spend on Drospirenone?
In 2024, Medicare Part D spent $2 million on Drospirenone across 6,063 claims for 1,718 beneficiaries.
How many Drospirenone products are on the market?
The Drospirenone drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Drospirenone?
NADAC reference prices for Drospirenone range from $6.6124 to $6.6124 per EA.
Which manufacturers make Drospirenone?
1 manufacturer lists Drospirenone in NADAC. Ranked by number of NDCs, the largest are Exeltis USA, Inc. (2).
How has the price of Drospirenone changed recently?
Over the past 7 days, 0 Drospirenone NDCs rose and 2 fell, with a market-wide average change of -0.0%.